SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DeadHead who wrote (180)12/25/1996 12:57:00 PM
From: r q lad   of 1172
 
Gordon, you are right.

Hope I didn't mislead you. I was disappointed in J&J's roll-out of the product (then called Accumeter). After CMTR dis-ingaged from J&J, I was still disappointed in the handling of Cholestrak which until now has severely underperformed relative to it's potential.

Got ahold of the full press release today, and Chemtrak is saying that sales of Cholestrak are improving. The managment changes they are making sound real positive, Ms Hunt's qualifications & experience are impressive and needed by CMTR at this point. I'm still very bullish on CMTR, just disappointed in their execution to date.

Regards,
R Lad
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News